Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shalin Patel

Orthopaedic Surgery Bloomfield, NJ Medical Doctor

NPI 1124387881 CMS profile 3506726

1455 Broad St Ste 250, Bloomfield, NJ 07003

Open in the dashboard

General payments

$51,732

157 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shalin Patel of Bloomfield, NJ is reported in the CMS Open Payments database as having received $51,732 across 157 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,507 21
2024 General $12,265 38
2023 General $8,810 25
2022 General $21,255 25
2021 General $1,396 17
2020 General $2,170 15
2019 General $1,328 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shalin Patel
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Shalin Patel were reported at $4,507. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Shalin Patel Orthopaedic Surgery median Middle half National median
2019 $1,328 $644 $140–$2,844 $163
2020 $2,170 $312 $75–$1,860 $114
2021 $1,396 $520 $117–$2,495 $132
2022 $21,255 $598 $128–$2,731 $149
2023 $8,810 $461 $128–$2,264 $160
2024 $12,265 $497 $134–$2,475 $164
2025 $4,507 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Precision Spine, Inc. $27,426 24 payments
  2. Kuros Biosciences USA, Inc $6,667 10 payments
  3. Spine Wave, Inc. $2,193 6 payments
  4. 4WEB, Inc. $2,193 10 payments
  5. Medtronic, Inc. $1,937 17 payments
  6. Medical Device Business Services, Inc. $1,756 9 payments
  7. Spineology Inc. $1,656 7 payments
  8. Stryker Corporation $1,418 17 payments
  9. SI-BONE, Inc. $1,182 4 payments
  10. RTI Surgical, Inc. $1,115 2 payments
  11. Other $4,186 51 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $23,650 12 payments
  2. Food and Beverage $11,618 125 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,000 1 payment
  4. Travel and Lodging $7,464 19 payments
Products named General payments · program years 2019–2025
  1. SURELOK MIS 3L $13,171 4 payments
  2. MD-VUE LATERAL ACCESS SYSTEM Orthopedics $9,671 3 payments
  3. REFORM TI CT MODULAR MIS PEDICLE SCREW SYSTEM $8,470 5 payments
  4. Dakota ACDF System $8,000 2 payments
  5. NEXGEN ANTERIOR CERVICAL PLATE SYSTEM $8,000 2 payments
  6. MAGNETOS $6,667 10 payments
  7. DAKOTA ALIF SYSTEM $4,485 10 payments
  8. MD-VUE LATERAL ACCESS SYSTEM Orthopedics $2,500 2 payments
  9. SPINE TRUSS SYSTEM $2,193 10 payments
  10. INTERVERTEBRAL BODY FUSION DEVICE $2,000 1 payment
  11. Other $13,417 112 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

131

Median for Orthopedic Surgery: 203

Drug cost

$756

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cyclobenzaprine Hcl Generic 39 $303
Gabapentin Generic 31 $191
Meloxicam Generic 36 $110
Oxycodone Hcl Generic 12 $102
Tramadol Hcl Generic 13 $50

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$197,164

Medicare's payments for the services billed

Medicare patients

697

Average age 73

Services billed

1,640

404 women, 293 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 35%
Diabetes 32%
Depression 26%
Chronic kidney disease 23%
Osteoporosis 19%
Atrial fibrillation 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

157 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record